Group One Trading, L.P. Esperion Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.81 Billion
Q3 2025

A detailed history of Group One Trading, L.P. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 162,589 shares of ESPR stock, worth $471,508. This represents 0.02% of its overall portfolio holdings.

Number of Shares

162,589

Previous 228,125 28.73%

Holding current value

$471,508

Previous $223,000 92.83%

% of portfolio

0.02%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$0.98 - $2.84 $64,225 - $186,122	-65,536 Reduced 28.73%	162,589 $430,000
Q2 2025 Aug 13, 2025	BUY	$0.73 - $1.41 $57,234 - $110,549	78,404 Added 52.37%	228,125 $223,000
Q1 2025 May 14, 2025	BUY	$1.44 - $2.34 $75,725 - $123,053	52,587 Added 54.14%	149,721 $215,000
Q4 2024 Feb 14, 2025	SELL	$1.61 - $3.83 $139,292 - $331,360	-86,517 Reduced 47.11%	97,134 $213,000
Q3 2024 Nov 14, 2024	BUY	$1.61 - $2.73 $267,578 - $453,720	166,198 Added 952.26%	183,651 $303,000

Q2 2024 Aug 14, 2024	SELL	$1.84 - $3.24 $190,083 - $334,711	-103,306 Reduced 85.55%	17,453 $38,000
Q1 2024 May 10, 2024	BUY	$2.02 - $3.02 $243,933 - $364,692	120,759 New	120,759 $323,000
Q3 2023 Nov 09, 2023	SELL	$0.96 - $1.79 $10,586 - $19,740	-11,028 Reduced 3.43%	310,778 $304,000
Q2 2023 Aug 09, 2023	SELL	$1.2 - $1.76 $30,124 - $44,183	-25,104 Reduced 7.24%	321,806 $447,000
Q1 2023 May 12, 2023	BUY	$1.46 - $7.3 $124,916 - $624,580	85,559 Added 32.74%	346,910 $551,000
Q4 2022 Feb 09, 2023	BUY	$5.09 - $8.5 $1.33 Million - $2.22 Million	261,351 New	261,351 $1.63 Million
Q4 2021 Feb 11, 2022	SELL	$4.81 - $11.92 $75,776 - $187,787	-15,754 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.34 - $21.37 $44,736 - $84,304	-3,945 Reduced 20.03%	15,754 $190,000
Q2 2021 Aug 10, 2021	BUY	$19.4 - $28.71 $156,305 - $231,316	8,057 Added 69.21%	19,699 $417,000
Q1 2021 May 12, 2021	BUY	$25.12 - $36.89 $292,447 - $429,473	11,642 New	11,642 $327,000
Q3 2019 Nov 12, 2019	SELL	$34.47 - $47.53 $416,328 - $574,067	-12,078 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$40.1 - $52.33 $39,217 - $51,178	978 Added 8.81%	12,078 $562,000
Q1 2019 May 13, 2019	BUY	$40.11 - $53.57 $313,259 - $418,381	7,810 Added 237.39%	11,100 $446,000
Q4 2018 Feb 06, 2019	SELL	$36.99 - $59.11 $217,982 - $348,335	-5,893 Reduced 64.17%	3,290 $151,000
Q3 2018 Nov 08, 2018	SELL	$40.74 - $51.41 $1.17 Million - $1.48 Million	-28,708 Reduced 75.76%	9,183 $407,000
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $653,880 - $1.38 Million	18,063 Added 91.1%	37,891 $1.49 Million
Q1 2018 May 11, 2018	BUY	$65.94 - $80.76 $988,242 - $1.21 Million	14,987 Added 309.58%	19,828 $1.43 Million
Q4 2017 Feb 09, 2018	BUY	$43.47 - $67.43 $210,438 - $326,428	4,841 New	4,841 $319,000
Q3 2017 Nov 15, 2017	SELL	$43.8 - $52.77 $473,477 - $570,443	-10,810 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	10,810	10,810 $500,000

Others Institutions Holding ESPR

# of Institutions

215

Shares Held

114M

Call Options Held

643K

Put Options Held

769K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $193M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Esperion Therapeutics, Inc. Transaction History